ZoomInfo Technologies (GTM) Earnings Analysis
ZoomInfo Technologies (GTM) has no confirmed upcoming earnings date. Last quarter (2026-05-11) it beat with EPS 0.28 USD vs 0.26 USD est (+7.7%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 7.47.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does GTM next report earnings?
No confirmed upcoming earnings date is currently scheduled for GTM. This page updates as the calendar is published.
GTM earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | 0.28 USD | 0.26 USD | +7.7% | Beat |
| 2026-02-09 | 0.32 USD | 0.28 USD | +14.3% | Beat |
| 2025-11-03 | 0.18 USD | 0.17 USD | +5.9% | Beat |
| 2025-08-04 | 0.25 USD | 0.23 USD | +8.7% | Beat |
| 2025-05-12 | 0.15 USD | 0.22 USD | -31.8% | Miss |
| 2024-08-05 | 0.17 USD | 0.24 USD | -29.2% | Miss |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
GTM valuation and analyst view
| Trailing P/E | 7.47 |
|---|---|
| Trailing EPS | 0.39287 USD |
| Price / book | 0.64 |
| Dividend yield | 0.00% |
| Market cap | 0.86B |
| Analyst consensus | Hold (6 buy / 16 hold / 7 sell) |
| Avg price target | 4.46 USD |
Related research pages
Frequently asked questions
When is ZoomInfo Technologies (GTM)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for GTM. This page updates as the calendar is published.
Did GTM beat earnings last quarter?
In its 2026-05-11 report, GTM posted EPS of 0.28 USD versus a 0.26 USD estimate — a beat of 7.7%.
What is GTM's earnings track record?
Over the last 6 reported quarters with consensus data, GTM beat estimates 4 times (67%).
What is GTM's current P/E ratio and EPS?
GTM trades at a trailing P/E of 7.47 on trailing EPS of 0.39286821705426356 USD.
What do analysts rate GTM?
Analyst consensus is "Hold" across 29 ratings (0 strong buy, 6 buy, 16 hold, 7 sell, 0 strong sell). Average 12-month price target: 4.46 USD.